Please login to the form below

Not currently logged in

Sanofi’s US pharma head joins Synta as CEO

Anne Whitaker also has experience at GSK

Synta Pharmaceuticals has named the former head of Sanofi's pharma operations in the US and Canada as its new CEO.

Anne Whitaker served as president, North America pharmaceuticals, at Sanofi since September 2011 overseeing all pharma and consumer healthcare operations within the region. She also served as a member of Sanofi's global leadership team, global commercial operations committee and US regional management committee.

She now leads an emerging US-based biopharma focused on the development of small molecule drugs to treat patients with severe medical conditions, including cancer and chronic inflammatory diseases.

“Synta presents an exciting opportunity defined by a late stage product, ganetespib, that has shown promising activity in multiple indications and a pre-clinical programme, HDC, that has significant potential to generate new drug candidates,” said Whitaker.

Prior to joining Sanofi in 2011, Whitaker spent nearly two decades at GlaxoSmithKline (GSK), progressing through the ranks to eventually hold a senior VP role. She began her career at Delta Communications before joining the Upjohn Company in 1991 as a metabolic disease specialist.

14th August 2014


Featured jobs

Subscribe to our email news alerts


Add my company

Conversis is a translation company specialising in translation and localisation for the Life Science and Pharmaceutical industry, with particular focus...

Latest intelligence

When is it time to rebrand?
The Biosimilar Challenge
How health behaviours and clinical outcomes are related
When HCPs understand patient activation levels they can actively guide patients towards more confident self-management of diverse health concerns....